Loading...
NPI 1942489356 · Fullerton, CA · Retina Specialist (Ophthalmology) Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Ash Pirouz is a retina specialist (ophthalmology) physician provider located in Fullerton, California. This profile covers 19 Medicare and 6 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Ash Pirouz |
| Address | 301 W Bastanchury Rd Ste 285 |
| City | Fullerton |
| State | CA |
| ZIP | 92835 |
| Taxonomy | Retina Specialist (Ophthalmology) Physician |
| NPI Enumerated | November 1, 2007 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $3.1M |
| Medicaid | $1.3M |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
19 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J2777 | Injection, faricimab‑svoa, 0.1 mg | 57,120 | $30 | $1.7M |
| J0178 | Injection, aflibercept, 1 mg | 690 | $690 | $472K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 2,670 | $110 | $283K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 1,660 | $100 | $168.9K |
| J3490 | Unclassified drugs | 70 | $1,770 | $128.8K |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 800 | $120 | $95.4K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 2,370 | $30 | $80.5K |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 320 | $220 | $68K |
| 92242 | The provider injects two different special dyes into one or both eyes that cause the blood vessels to stand out in photographic images timed so that multiple frames are taken in rapid succession. He… | 220 | $240 | $51K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 130 | $130 | $17.2K |
Showing 1–10 of 19
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 19 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
19 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J0178 | 144 | 310 | 570 | $690 | $647.1K |
| J2777 | 6 | 200 | 10,740 | $30 | $459.5K |
| Q5128 | 38 | 50 | 800 | $220 | $286.7K |
| J2781 | 15 | 60 | 480 | $120 | $95.7K |
| 67028 | 57 | 470 | 420 | $100 | $71.8K |
| J3490 | 168 | 320 | 80 | $190 | $49.2K |
| 92242 | 8 | 30 | 80 | $230 | $36.3K |
| J7999 | 89 | 240 | 130 | $140 | $34.9K |
| 99214 | 109 | 37,970 | 120 | $90 | $23.2K |
| 92235 | 92 | 270 | 60 | $110 | $17.1K |
Showing 1–10 of 19
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
6 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 1,290 | $420 | $543.1K |
| J0178 | Injection, aflibercept, 1 mg | 230 | $1,650 | $377.1K |
| J2777 | Injection, faricimab‑svoa, 0.1 mg | 140 | $1,550 | $221.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,920 | $50 | $92K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 1,980 | $30 | $63.3K |
| J9035 | Injection, bevacizumab, 10 mg | 540 | $70 | $39.1K |
How this provider's Medicaid billing volume and revenue compare to other California providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. California median
6 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 68 | 120 | 380 | $970 | $1.1M |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 144 | 360 | 840 | $160 | $495.3K |
| J2777 | Injection, faricimab‑svoa, 0.1 mg | 14 | 30 | 120 | $1,020 | $318.4K |
| J9035 | Injection, bevacizumab, 10 mg | 95 | 230 | 310 | $110 | $232K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 4,218 | 13,300 | 640 | $40 | $169.6K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 189 | 700 | 420 | $20 | $60.3K |
Other providers in the same ZIP code as Ash Pirouz, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Sean Adrean | CA | Retina Specialist (Ophthalmology) Physician | $3.1M | $163.9K |
| Hema Ramkumar | CA | Retina Specialist (Ophthalmology) Physician | $2M | $54.9K |
| Kevin Jackson | CA | Medical Physician Assistant | $884.3K | $0 |
| Lutfi Sayyur | CA | Hospitalist Physician | $829.4K | $0 |
| Wei Kwok | CA | Pain Medicine (Anesthesiology) Physician | $181.2K | $580.8K |
| Fullerton Surgical Center, LP | CA | Ambulatory Surgical Clinic/Center | $616.4K | $0 |
| Phillip Ho | CA | Psychiatric/Mental Health Nurse Practitioner | $579.9K | $0 |
| William Baugh | CA | Dermatology Physician | $489.8K | $0 |
| Preferred Sleep Solutions | CA | Sleep Disorder Diagnostic Clinic/Center | $167.9K | $301.8K |
| Jack Florin | CA | Neurology Physician | $446.9K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.